MONTREAL, Oct. 3 /CNW Telbec/ - BioContact Québec will host two panels of
leading figures in the U.S. financial communities. All focus completely or in
large measure on life sciences and all share a common interest in expanding
their involvement with Canadian companies.
The first panel will consist of venture capital and private equity
investors. The second will include investment bankers of various sizes and
interests, actively engaged in raising funds for Canadian life science
companies. Both panels will focus on investment criteria, stage of
development, terms and substantive interests.
James Garvey, Managing Partner - SV Life Sciences
Dominique Semon, chief Investment Officer - Merlin Biomed Group
Ron Laufer, Managing Director, Lilly BioVentures
Ken Sorensen, Managing Partner, Array Capital LLC
Art Pappas, Managing Partner, Am PappasVentures
Stuart Barich, Managing Director - Oppenheimer & Co.
Edwin Gordon, Managing Director - Merriman Curhan Ford & Co.
Mark Epstein, Managing Director - Bank of America Securities LLC
Michael K. Levitan, , Managing Director - Trout Capital LLC
Jonathan Gertler, Managing Partner, Leerink Swann & Co.
Len Schleicher, Vice President, Capital Markets - Taglich Brothers
The event will be held at Le Château Frontenac (Salon Rose) in Quebec
City, at 2:00 pm.
For further information:
For further information: Hélène Turcotte, Press Room Coordinator,
BioContact 2007, (418) 573-4046